Skip to main content
Figure 3 | BMC Cancer

Figure 3

From: Kinetic Targeting of pegylated liposomal Doxorubicin: a new Approach to Reduce Toxicity during Chemotherapy (CARL-trial)

Figure 3

QLQ-C30 Scores. To address quality of life during chemotherapy, the QLQ-C30 questionnaire was used [17]. The scores were calculated according to the manual. The questionnaire was filled after the first cycle (timepoint 1) and after the last cycle (timepoint 2), 10 patients were eligible completing 4 (n = 9) or 6 (n = 1) cycles. (A) Functional scores (high score corresponds to high functionality) (B) Symptom scores (low score correspond to mild symptoms).

Back to article page